Erythropoietin Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Publisher Name :
Date: 30-Apr-2020
No. of pages: 91

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

This report contains market size and forecasts of Erythropoietin in US, including the following market information:

US Erythropoietin Market Revenue, 2015-2020, 2021-2026, ($ millions)

US Erythropoietin Market Consumption, 2015-2020, 2021-2026, (M Units)

US Erythropoietin Production Capacity, 2015-2020, 2021-2026, (M Units)

Top Five Competitors in US Erythropoietin Market 2019 (%)

The global Erythropoietin market was valued at 8382.6 million in 2019 and is projected to reach US$ 10400 million by 2026, at a CAGR of 5.6% during the forecast period. While the Erythropoietin market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erythropoietin manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.

This report also analyses and evaluates the COVID-19 impact on Erythropoietin production and consumption in US

Total Market by Segment:

US Erythropoietin Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Units)

US Erythropoietin Market Segment Percentages, By Type, 2019 (%)

- Epoetin-alfa

- Epoetin-beta

- Darbepoetin-alfa

- Others

US Erythropoietin Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Units)

US Erythropoietin Market Segment Percentages, By Application, 2019 (%)

- Anemia

- Kidney Disorders

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Erythropoietin Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)

Total Erythropoietin Market Competitors Revenues Share in US, by Players 2019 (%)

Total US Erythropoietin Market Competitors Sales, by Players 2015-2020 (Estimated), (M Units)

Total US Erythropoietin Market Competitors Sales Market Share by Players 2019 ($ millions)

Further, the report presents profiles of competitors in the market, including the following:

- Amgen

- Johnson & Johnson

- Roche

- Galenica

- Emcure

- Kyowa Hakko Kirin

- 3SBio

- Biocon

Erythropoietin Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Erythropoietin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 US Erythropoietin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: US Erythropoietin Overall Market Size
2.1 US Erythropoietin Market Size: 2020 VS 2026
2.2 US Erythropoietin Revenue, Prospects & Forecasts: 2015-2026
2.3 US Erythropoietin Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Erythropoietin Players in US (including Foreign and Local Companies)
3.2 Top US Erythropoietin Companies Ranked by Revenue
3.3 US Erythropoietin Revenue by Companies (including Foreign and Local Companies)
3.4 US Erythropoietin Sales by Companies (including Foreign and Local Companies)
3.5 US Erythropoietin Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Erythropoietin Companies in US, by Revenue in 2019
3.7 US Manufacturers Erythropoietin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Erythropoietin Players in US
3.8.1 List of US Tier 1 Erythropoietin Companies
3.8.2 List of US Tier 2 and Tier 3 Erythropoietin Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - US Erythropoietin Market Size Markets, 2020 & 2026
4.1.2 Epoetin-alfa
4.1.3 Epoetin-beta
4.1.4 Darbepoetin-alfa
4.1.5 Others
4.2 By Type - US Erythropoietin Revenue & Forecasts
4.2.1 By Type - US Erythropoietin Revenue, 2015-2020
4.2.2 By Type - US Erythropoietin Revenue, 2021-2026
4.2.3 By Type - US Erythropoietin Revenue Market Share, 2015-2026
4.3 By Type - US Erythropoietin Sales & Forecasts
4.3.1 By Type - US Erythropoietin Sales, 2015-2020
4.3.2 By Type - US Erythropoietin Sales, 2021-2026
4.3.3 By Type - US Erythropoietin Sales Market Share, 2015-2026
4.4 By Type - US Erythropoietin Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Erythropoietin Market Size, 2020 & 2026
5.1.2 Anemia
5.1.3 Kidney Disorders
5.1.4 Others
5.2 By Application - US Erythropoietin Revenue & Forecasts
5.2.1 By Application - US Erythropoietin Revenue, 2015-2020
5.2.2 By Application - US Erythropoietin Revenue, 2021-2026
5.2.3 By Application - US Erythropoietin Revenue Market Share, 2015-2026
5.3 By Application - US Erythropoietin Sales & Forecasts
5.3.1 By Application - US Erythropoietin Sales, 2015-2020
5.3.2 By Application - US Erythropoietin Sales, 2021-2026
5.3.3 By Application - US Erythropoietin Sales Market Share, 2015-2026
5.4 By Application - US Erythropoietin Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Amgen
6.1.1 Amgen Corporate Summary
6.1.2 Amgen Business Overview
6.1.3 Amgen Erythropoietin Major Product Offerings
6.1.4 Amgen Sales and Revenue in US (2015-2020)
6.1.5 Amgen Key News
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporate Summary
6.2.2 Johnson & Johnson Business Overview
6.2.3 Johnson & Johnson Erythropoietin Major Product Offerings
6.2.4 Johnson & Johnson Sales and Revenue in US (2015-2020)
6.2.5 Johnson & Johnson Key News
6.3 Roche
6.3.1 Roche Corporate Summary
6.3.2 Roche Business Overview
6.3.3 Roche Erythropoietin Major Product Offerings
6.3.4 Roche Sales and Revenue in US (2015-2020)
6.3.5 Roche Key News
6.4 Galenica
6.4.1 Galenica Corporate Summary
6.4.2 Galenica Business Overview
6.4.3 Galenica Erythropoietin Major Product Offerings
6.4.4 Galenica Sales and Revenue in US (2015-2020)
6.4.5 Galenica Key News
6.5 Emcure
6.5.1 Emcure Corporate Summary
6.5.2 Emcure Business Overview
6.5.3 Emcure Erythropoietin Major Product Offerings
6.5.4 Emcure Sales and Revenue in US (2015-2020)
6.5.5 Emcure Key News
6.6 Kyowa Hakko Kirin
6.6.1 Kyowa Hakko Kirin Corporate Summary
6.6.2 Kyowa Hakko Kirin Business Overview
6.6.3 Kyowa Hakko Kirin Erythropoietin Major Product Offerings
6.6.4 Kyowa Hakko Kirin Sales and Revenue in US (2015-2020)
6.6.5 Kyowa Hakko Kirin Key News
6.7 3SBio
6.6.1 3SBio Corporate Summary
6.6.2 3SBio Business Overview
6.6.3 3SBio Erythropoietin Major Product Offerings
6.4.4 3SBio Sales and Revenue in US (2015-2020)
6.7.5 3SBio Key News
6.8 Biocon
6.8.1 Biocon Corporate Summary
6.8.2 Biocon Business Overview
6.8.3 Biocon Erythropoietin Major Product Offerings
6.8.4 Biocon Sales and Revenue in US (2015-2020)
6.8.5 Biocon Key News
6.9 LG Life Sciences
6.9.1 LG Life Sciences Corporate Summary
6.9.2 LG Life Sciences Business Overview
6.9.3 LG Life Sciences Erythropoietin Major Product Offerings
6.9.4 LG Life Sciences Sales and Revenue in US (2015-2020)
6.9.5 LG Life Sciences Key News

7 Erythropoietin Production Capacity, Export and Import Analysis
7.1 Erythropoietin Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
7.1.1 US Erythropoietin Production Capacity, 2015-2026
7.1.2 US Erythropoietin Production 2015-2026
7.1.3 US Erythropoietin Production Value 2015-2026
7.2 Key Local Erythropoietin Manufacturers in US
7.2.1 US Key Local Erythropoietin Manufacturers Production Capacity
7.2.2 US Key Local Erythropoietin Manufacturers Production
7.2.3 US Key Local Erythropoietin Manufacturers Production Value
7.2.4 The Proportion of Erythropoietin Production Sold in US and Sold Other Than US by Manufacturers
7.3 Erythropoietin Export and Import in US
7.3.1 US Erythropoietin Export Market
7.3.2 US Erythropoietin Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for US Erythropoietin Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Erythropoietin Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Erythropoietin Distributors and Sales Agents in US

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List of Tables
Table 1. Key Players of Erythropoietin in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Erythropoietin Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Erythropoietin Revenue Share by Companies, 2015-2020
Table 5. US Erythropoietin Sales by Companies, (M Units), 2015-2020
Table 6. US Erythropoietin Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Erythropoietin Price (2015-2020) (USD/Unit)
Table 8. US Manufacturers Erythropoietin Product Type
Table 9. List of US Tier 1 Erythropoietin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Erythropoietin Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Erythropoietin Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Erythropoietin Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Erythropoietin Sales in US (M Units), 2015-2020
Table 14. By Type - Erythropoietin Sales in US (M Units), 2021-2026
Table 15. By Application - Erythropoietin Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Erythropoietin Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Erythropoietin Sales in US, (M Units), 2015-2020
Table 18. By Application - Erythropoietin Sales in US, (M Units), 2021-2026
Table 19. Amgen Corporate Summary
Table 20. Amgen Erythropoietin Product Offerings
Table 21. Amgen Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Johnson & Johnson Corporate Summary
Table 23. Johnson & Johnson Erythropoietin Product Offerings
Table 24. Johnson & Johnson Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Roche Corporate Summary
Table 26. Roche Erythropoietin Product Offerings
Table 27. Roche Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Galenica Corporate Summary
Table 29. Galenica Erythropoietin Product Offerings
Table 30. Galenica Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Emcure Corporate Summary
Table 32. Emcure Erythropoietin Product Offerings
Table 33. Emcure Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Kyowa Hakko Kirin Corporate Summary
Table 35. Kyowa Hakko Kirin Erythropoietin Product Offerings
Table 36. Kyowa Hakko Kirin Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 37. 3SBio Corporate Summary
Table 38. 3SBio Erythropoietin Product Offerings
Table 39. 3SBio Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 40. Biocon Corporate Summary
Table 41. Biocon Erythropoietin Product Offerings
Table 42. Biocon Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 43. LG Life Sciences Corporate Summary
Table 44. LG Life Sciences Erythropoietin Product Offerings
Table 45. LG Life Sciences Erythropoietin Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 46. Erythropoietin Production Capacity (M Units) of Local Manufacturers in US, 2015-2020
Table 47. Erythropoietin Production (M Units) of Local Manufacturers in US, 2015-2020
Table 48. US Erythropoietin Production Market Share of Local Manufacturers, 2015-2020
Table 49. Erythropoietin Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 50. US Erythropoietin Production Value Market Share of Local Manufacturers, 2015-2020
Table 51. The Percentage of Erythropoietin Production Sold in US and Sold Other Than US by Manufacturers
Table 52. The Percentage of Erythropoietin Production Sold in US and Sold Other Than US by Manufacturers
Table 53. Dangeguojia Erythropoietin Sales (Consumption), Production, Export and Import, 2015-2020
Table 54. Raw Materials and Suppliers
Table 55. Erythropoietin Downstream Clients in US
Table 56. Erythropoietin Distributors and Sales Agents in US
List of Figures
Figure 1. Erythropoietin Segment by Type
Figure 2. Erythropoietin Segment by Application
Figure 3. Dangeguojia Erythropoietin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Erythropoietin Market Size in US, (US$, Mn) & (M Units): 2020 VS 2026
Figure 6. US Erythropoietin Revenue, 2015-2026 (US$, Mn)
Figure 7. Erythropoietin Sales in US: 2015-2026 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Erythropoietin Revenue in 2019
Figure 9. By Type - US Erythropoietin Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Erythropoietin Market Share, 2015-2020
Figure 11. By Type - US Erythropoietin Market Share, 2020-2026
Figure 12. By Type - US Erythropoietin Price (USD/Unit), 2015-2026
Figure 13. By Application - Erythropoietin Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Erythropoietin Market Share, 2015-2020
Figure 15. By Application - US Erythropoietin Market Share, 2020-2026
Figure 16. By Application -US Erythropoietin Price (USD/Unit), 2015-2026
Figure 17. US Erythropoietin Production Capacity (M Units), 2015-2026
Figure 18. US Erythropoietin Actual Output (M Units), 2015-2026
Figure 19. US Erythropoietin Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Erythropoietin Export Destination, 2019
Figure 21. The Source of Imports of US Erythropoietin, 2019
Figure 22. PEST Analysis for US Erythropoietin Market in 2020
Figure 23. Erythropoietin Market Opportunities & Trends in US
Figure 24. Erythropoietin Market Drivers in US
Figure 25. Erythropoietin Market Restraints in US
Figure 26. Erythropoietin Industry Value Chain
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs